ArticleAmerican journal of respiratory cell and molecular biology2022

Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.

Jae-Hyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.